Objectives: Although carbon dioxide laser vaporization is frequently used for treating vaginal intraepithelial neoplasia (VaIN), the optimal depth of epithelial destruction with laser vaporization requires elucidation. We aimed to evaluate VaIN depth and better illustrate epithelial destruction during laser vaporization.

Materials And Methods: We included 246 women diagnosed with VaIN (low-grade VaIN [VaIN 1], 123 women; high-grade VaIN [VaIN 2/3], 123 women) using colposcopy-directed biopsy at our hospital from January 1, 2019, to April 30, 2020. The thickness of the noninvolved epithelium, if available, was determined. All available data, including cytology and histological information, were recorded. The t test and Pearson χ 2 test were used for statistical analysis. Statistical significance was set at p < .05.

Results: The involved epithelial thicknesses in VaIN 2/3 and VaIN 1 were 0.41 ± 0.21 and 0.40 ± 0.19 mm, respectively, which were both greater than their noninvolved epithelial thickness values (0.17 ± 0.10 and 0.17 ± 0.08 mm, p < .01 and p < .01, respectively). In subgroup comparisons between the VaIN 2/3 and VaIN 1 groups, the involved epithelial thickness did not differ between premenopausal patients, postmenopausal women receiving estrogen, and postmenopausal women who did not receive estrogen ( p > .05). In the VaIN 2/3 group, the lesion thickness in premenopausal was greater than that in postmenopausal women receiving estrogen ( p = .016) and those who were not receiving estrogen ( p = .017).

Conclusions: The thickness of VaIN is generally less than 1 mm for women of all ages, except in rare cases of visible lesions with papillary hyperplasia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232286PMC
http://dx.doi.org/10.1097/LGT.0000000000000672DOI Listing

Publication Analysis

Top Keywords

vain 2/3
12
postmenopausal women
12
receiving estrogen
12
vain
11
vaginal intraepithelial
8
intraepithelial neoplasia
8
laser vaporization
8
epithelial destruction
8
destruction laser
8
vain [vain
8

Similar Publications

Aim: We investigated the frequency of early recurrence of vaginal intraepithelial neoplasia grade 2/3 (VaIN 2/3) (within 2 years) after hysterectomy for cervical intraepithelial neoplasia grade 3 (CIN3). The characteristics of the clinicopathological factors common to them were explored including different surgical methods.

Methods: As a retrospective observational study, a total of 647 CIN3 patients were divided into a conization and hysterectomy group (C group, n = 492; H group, n = 155), and HSIL (CIN2/3 or VaIN2/3) recurrence within 2 years after surgery was evaluated.

View Article and Find Full Text PDF
Article Synopsis
  • The European Society of Gynaecological Oncology and other organizations created consensus statements to enhance care for patients with vaginal intraepithelial neoplasia (VaIN).
  • Treatment for VaIN depends on the lesion's grade, with follow-ups for low-grade VaIN (VaIN 1) and treatment required for high-grade (VaIN 2-3), highlighting that management should be personalized.
  • Surgical excision is the primary treatment; alternatives like CO laser and topical agents exist, with imiquimod showing the best outcomes, while brachytherapy is suited for specific cases, and consistent follow-up is essential due to the recurring nature of VaIN.
View Article and Find Full Text PDF
Article Synopsis
  • The consensus statements developed by ESGO, ISSVD, ECSVD, and EFC aim to enhance care for patients with vaginal intraepithelial neoplasia (VaIN), outlining management strategies based on lesion grade.
  • For low-grade VaIN (VaIN 1), follow-up is usually sufficient, while high-grade VaIN (VaIN 2-3) requires treatment, with surgical excision being the primary method if invasion is suspected.
  • Treatments like CO2 laser and topical agents, especially Imiquimod, are effective, but surgical options are often necessary for cases post-hysterectomy, and patients should be closely monitored due to the risk of recurrence.
View Article and Find Full Text PDF

Background: Vaginal high-grade squamous intraepithelial lesion (HSIL) (vaginal intraepithelial neoplasia [VAIN] grade 2-3) is clinically, a precancerous lesion condition with an estimated progression rate of 10%-20%. Therefore, treatment is recommended. Because traditional treatments have limited effects, high expense and complications, here we evaluated the efficacy and safety of topical 5-aminolevulinic acid (ALA)-based photodynamic therapy (PDT).

View Article and Find Full Text PDF

Objectives: Although carbon dioxide laser vaporization is frequently used for treating vaginal intraepithelial neoplasia (VaIN), the optimal depth of epithelial destruction with laser vaporization requires elucidation. We aimed to evaluate VaIN depth and better illustrate epithelial destruction during laser vaporization.

Materials And Methods: We included 246 women diagnosed with VaIN (low-grade VaIN [VaIN 1], 123 women; high-grade VaIN [VaIN 2/3], 123 women) using colposcopy-directed biopsy at our hospital from January 1, 2019, to April 30, 2020.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!